CANBCAN B CORP.

About CAN B CORP. (CANB)

CAN B CORP. (CANB) is a Drug Manufacturers - Specialty & Generic company headquartered in Hicksville, NY, United States whose shares trade over-the-counter on the OTCQB tier.

Our patent portfolio held by Can B Corp. in its Nascent Pharma, LLC Division includes three issued patents with claims to popular cannabis and hemp-based products and manufacturing methods that dominate the cannabis, hemp and CBD industry. The Can B patents were tested in an earlier litigation, survived, and now benefit from several favorable court rulings. The targeted industry includes the major cannabis industry leaders and supports a substantial damage model. The monetization project discussed below justifies the significant investment necessary for success.

Products and services

Can B Corps Nascent Pharma LLC Division is a forward-thinking pharmaceutical Intellectual Property (IP) company, focused on maximizing the value of its cannabis patent portfolios.

CANB key facts

Ticker symbol

CANB

Market tier

OTCQB

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Hicksville, NY, United States

Country of incorporation

US

Year of incorporation

2005

Employees

5

Estimated market cap

$13.80M (as of Apr 9, 2025)

Shares outstanding

83,666,664

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

12/31

CAN B CORP. leadership

• Marco Alfonsi — CEO
• Stanley L. Teeple — CFO, Secretary
• Philip Dowd Forlenza — Securities Counsel

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · OTCQB stocks · OTC stocks starting with C